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1. Introduction  
While originally utilized primarily in prokaryotic organisms, reporter systems such as green 
fluorescent protein (GFP) and its variants, substrate dependent luciferase systems such as 
beetle and marine luciferase proteins, and substrate independent luciferase systems such as 
the bacterial luciferase gene cassette have now become the standards for imaging in the 
mammalian cellular background as well (Fig. 1). This has occurred in part because the use of 
cultured mammalian cells or small animal models has increased steadily over time in order 
to obtain more relevant human proxies for the measurement of cellular processes and 
bioavailability of biomedically relevant compounds of interest. However, the expression and 
detection of these reporter systems in eukaryotic models presents unique challenges not 
encountered in their prokaryotic counterparts. 
The differences in gene expression and cellular compartmentalization between prokaryotic 
and eukaryotic cells represent the major obstacles for the efficient expression of these and 
other reporter systems at the cellular level, but once the line has been crossed from 
expression in single cells to expression in multicelluar organisms, these problems can be 
compounded by the increases in absorption and scattering intrinsic to whole animal 
imaging.  As a result, much consideration must be given to the experimental design 
associated with bioluminescent or fluorescent detection from mammalian cells.  The type of 
system employed, whether it be cell culture or whole animal, the depth of imaging, the 
relevant time period available for data collection, and even the ability to distinguish 
multiple reporter systems from within the same tissue must be understood and 
acknowledged prior to beginning any experiment. 
To better prepare for selection of the most appropriate reporter protein for the detection of a 
bioluminescent or fluorescent signal from mammalian tissue, this chapter will highlight and 
compare the utility of the most commonly available reporter systems as reported in the 
current literature.  Specifically, the chapter will focus on the green fluorescent protein (GFP) 
and its color shifted variants, D-luciferin based luciferase proteins (both from the firefly and 
from click beetles), coelenterazine based luciferase proteins (those from the Renilla and 
Gaussia genera), and the bacterial luciferase gene cassette (lux). A short background of the 
major reporter proteins will be given that explains the biochemical requirements of each, as 
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well as the physical properties that make them unique (emission wavelength, quantum 
yield, etc.). These properties will be considered in relation to how they influence the ability 
to detect the resulting bioluminescent or fluorescent signal using commercially available 
equipment.   
 
 
Fig. 1. Bioluminescent detection from a small animal model.  
The luminescent (as shown here from cells expressing human codon-optimized bacterial 
luciferase genes) or fluorescent signals of a reporter cell line can be detected through the 
tissue of a living small animal host, allowing for localization of the cell population and 
estimation of its size without the need to sacrifice the host. 
To provide a better understanding of the function of each of the reporter systems, relevant 
examples will be cited that illustrate the common use of each reporter system, as well as 
novel examples that show how each can be adapted to function under unique circumstances 
based on their biochemical requirements and physical emission properties. The relative 
strengths and weaknesses of each of the considered reporter systems will also be discussed, 
with an eye towards their role in imaging cellular processes at the level of cell culture 
imaging, near surface detection through tissue in small animal models, and deep tissue 
(beyond subcutaneous) imaging in small animal models. The overall goal is to present a fair 
representation of the potential uses of each of the chosen reporter systems to allow for 
selection of the most appropriate system for a given experimental design. 
2. Imaging concerns in biological tissues 
There are additional concerns when performing data collection from within a living 
medium that must be considered in addition to the traditional focus on experimental 
efficiency.  The detection of a fluorescent or luminescent signal from within a tissue sample 
can be dependent on multiple factors, such as the total flux of photons capable of being 
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produced by the reporter, the population size of reporter cells that are introduced into the 
sample, and the location of those reporter cells within the tissue sample itself (Troy et al., 
2004).  Subsequently, the visualization of the reporter signal is dependent on the absorption 
and scattering of that signal prior to its detection.  One method for overcoming these 
detrimental conditions is to alter the emission wavelength of the reporter signal.  Increasing 
the wavelength can serve to both reduce the amount of scattering and decrease absorption. 
This is possible because the majority of photon absorption is the result of signal interaction 
with endogenous chromophoric material within the cell.  By moving to a longer, more red-
shifted emission wavelength, where the level of absorption within tissue is lower, it is 
possible to detect a greater amount of signal intensity than would be possible from an 
identical reporter with a lower, more blue-shifted emission wavelength (Chance et al., 1998).  
Because of this, it is paramount to consider the emission wavelength of a given reporter 
system, along with the other desired attributes of that reporter, prior to experimental design.  
For example, the bioluminescent signal from the bacterial bioluminescence (lux) reaction is 
produced at 490 nm.  This is relatively blue-shifted as compared to the firefly luciferase 
(Luc)-based bioluminescent probes that display their peak luminescent signal at 560 nm.  
The shorter wavelength of the lux-based signal has a greater chance of becoming attenuated 
within the tissue and therefore may not be as easily detected if it is used in deeper tissue 
applications such as intraperitoneal or intraorganellar injections into a small animal host.  To 
overcome the disadvantage of increased attenuation due to the shorter, blue-shifted 
emission wavelength, similar detection levels using the lux reporter would require a longer 
integration time than would be expected when using the longer wavelength Luc reporter 
following subcutaneous injection.   
It is important to remember that these effects are not specific to bioluminescent reporters 
and hold true when working with fluorescent reporter proteins as well.  However, when 
introducing a fluorescent reporter system into the mammalian cellular environment, one 
must take into account the effect that the excitation wavelength will have on overall 
detectability.  This is because the presence of the excitation signal can result in production of 
high levels of background autofluorescence under small animal imaging conditions, due to 
the presence of chromophoric material within the mammalian cell (Choy et al., 2003; Troy et 
al., 2004).  This can result in difficulty distinguishing the reporter excitation signal from the 
background noise if the two are produced at similar wavelengths.  Unlike a bioluminescent 
system, which does not require an excitation light signal, increasing the duration of this 
signal can lead to a reduction of measureable signal due to the combined results of 
photobleaching of the reactive photocenter of the reporter protein and the associated 
increase in background noise from extended excitation of endogenous chromophoric 
cellular material.  For this reason, the photostability of a particular fluorescent protein must 
be considered in addition to the general concerns of efficiency and brightness that should be 
weighed prior to selection of any reporter protein, fluorescent or bioluminescent, when 
designing any experiment. 
3. Green fluorescent protein (GFP) 
3.1 Introduction 
While the green fluorescent protein (GFP) is not the only fluorescent protein target used for 
visualization in the mammalian cellular background, it is certainly the most well known.  
Widespread familiarity with this reporter, coupled with its longstanding use in both 
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prokaryotic and eukaryotic organisms, is perhaps the major impetus that drives 
investigators to select it as a target for biomarker visualization.  The namesake 504 nm 
emission signal of GFP is relatively low (Patterson et al., 1997) in the green spectrum of 
visible light, making it a less than ideal candidate for high levels of fluorescent penetration 
through mammalian tissue (Chance et al., 1998). This disadvantage has been at least 
partially overcome by the introduction of mutated versions of the GFP protein that have 
been engineered to fluoresce at higher wavelengths where penetration is greater (Tsien, 
1998; Zimmer, 2002).  In addition, fluorescent proteins have since been introduced that 
successfully increase the emission wavelength of the fluorescent signal to a fully red-shifted 
wavelength for more efficient detection through tissue.  This was accomplished first with 
the introduction of the monomeric red fluorescent protein (mRFP1), derived from the red 
fluorescent protein of Discosoma sp. (Campbell, R. et al., 2002). Further engineering was then 
performed to develop more efficient variants such as the popular mCherry and tdTomato 
proteins in use today (Shaner et al., 2004).  Despite these advances in fluorescent reporter 
technology, GFP remains in high use, either in conjunction with or independent of these 
alternate reporter systems. When used properly, it can be an excellent reporter system for 
imaging in the mammalian cellular environment and serves as an excellent model for the 
function of fluorescent proteins in general. 
3.2 GFP structure 
Wild type GFP is composed of a single polypeptide consisting of 328 amino acids (Tsien, 
1998).  The mature protein forms an 11-stranded -barrel that is roughly twice as long as it is 
wide (diameter of 24 Å and height of 42 Å) (Zimmer, 2002).  The only exception to the -
sheet motif is the formation of two short -helices between the 7th and 8th -strands.  These 
two -helical sections act as lids to cover the open ends of the cylinder (Phillips, 1997) and 
support the formation of the fluorophore (Tsien, 1998).  This 11-stranded -sheet 
conformation is very unique and has been termed the -can.  It is hypothesized that the 
tight, almost seamless, structure imparted by the -can formation is what gives the GFP 
protein such a high level of resistance to denaturation by heat and chemical denaturants 
(Ward et al., 1982). 
The historical view of the mechanism suggests the fluorophore is autocatalytically formed 
post-translationally from the side chains of residues 65 – 67 (Phillips, 1997).  Following 
folding into a native conformation, the carbonyl of Ser 65 undergoes a nucleophilic attack 
from the amide of Gly 67 leading to formation of an imidazolinone.  Oxygen then 
dehydrogenates the - bond of Tyr 66 to bring its aromatic side chain into conjugation with 
the imidazolinone, allowing for absorbance and fluorescence to occur (Tsien, 1998).  More 
recently this mechanism has been revisited and it has been proposed that the position of 
backbone residues plays a greater role than initially thought (Fig. 2).  It is hypothesized that 
the tight -can structure holds the residues forming the fluorophore into position, allowing 
Arg 96 to initiate the acid base reactions required to form an intermediate that is stabilized 
by Glu 222 even though it is in an energetically unfavorable state.  This intermediate is then 
oxidized to the highly stable aromatic imidazolone and the fluorophore becomes active 
(Barondeau et al., 2003).  It is the formation and oxidation of the fluorophore that is the 
limiting step in the expression of a mature GFP protein, with the process taking as little as 45 
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minutes following protein synthesis in optimized protein constructs (Crameri et al., 1996) or 
as long as 4 hours in the wild type variant (Heim et al., 1994). 
 
 
Fig. 2. The proposed biosynthetic scheme for the chromophore of GFP. 
The freshly translated protein (upper left) could be trapped by inclusion bodies or remain 
soluable and nonfluorescent (upper center) until oxidation by O2, which could 
dehydrogenate Tyr 66 to form the fluorophore (upper right). The protonated and 
deprotonated species (upper and lower right) may be responsible for the 394 and 470 to 475 
nm excitation peaks, respectively. The excited state of phenols are much more acidic than 
their ground states, so that emission would come only from the deprotonated species.  
Originally published in (Heim et al., 1994).  Copyright by the National Academy of Sciences. 
While this Ser-Tyr-Gly triplet is common among known proteins, it alone is not sufficient to 
cause formation of a fluorophore.  What makes the sequence unique in GFP is a combination 
of steric positioning and acid/base chemistry with the surrounding residues. It is an 
absolute requirement that glycine be present in position 67, as no functional GFP mutants 
have been isolated with any other residue at this position (Phillips, 1997). The freedom 
allowed by the short side chain of glycine allows for proper positioning of the fluorophore 
so that it can properly interact with the surrounding residues (Zimmer, 2002).  These 
interactions provide immobilization of the fluorophore allowing for resonance stabilization 
under excited state conditions (Phillips, 1997). 
It is possible for the native GFP protein to exist as either a monomer or a dimer, with variant 
fluorescent signatures in either state (Phillips, 1997). This is in contrast to homologous 
proteins such as GFP from Renilla reniformis, which is an obligate dimer (Tsien, 1998).  It is 
generally accepted that whether or not GFP is isolated as a dimer or a monomer is 
dependent on the isolation conditions and not the result of any in vivo influences (Palm et 
al., 1997) and that the dissociation constant for the dimer is 100 M (Phillips, 1997).  
Dimerization is localized to the hydrophobic surface formed by the Ala 206, Leu 221, and 
Phe 223 residues and bolstered by a host of other hydrophilic contacts (Tsien, 1998).  When 
these contacts are made the structure of the fluorophore can be altered, presumptively 
because its tight immobilization relative to the backbone associated atoms of neighboring 
residues forces it to change orientation following bond rearrangement (Wu et al., 1996). 
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3.3 GFP mechanism of action 
The wild type GFP protein is able to absorb light at two different wavelengths. A minor 
peak occurs at 475 nm with the major peak at 397 nm. Regardless of which excitation 
wavelength is used, emission occurs only at 504 nm (Patterson et al., 1997). The different 
absorption peaks have been attributed to varying protonation states of the fluorophore, with 
the neutral state corresponding to the major absorption peak at 397 nm and the anionic form 
contributing to the minor peak at 475 nm (Niwa et al., 1996). The large shift between the 
major absorption peak at 397 nm and the emission at 504 nm can be attributed to an excited 
state proton transfer from the side chain of the Tyr 66 residues of the fluorophore (Chattoraj 
et al., 1996) to the carboxylate oxygen of Glu 222 (Zimmer, 2002). 
Based on this interconversion of the fluorophore, a three state model of photoisomerization 
has been put forward to explain the chemical basis for shifts in absorption. This model states 
that excitation of the neutral state fluorophore can cause conversion to the anionic form via 
an intermediate (Chattoraj et al., 1996).  The intermediate is structurally similar to the 
neutral form of the fluorophore, but has become deprotonated at the phenol group of Tyr 66 
(Zimmer, 2002).  Excitation of the anionic form is capable of directly emitting fluorescence, 
while the neutral state must necessarily convert into an excited form of this intermediate 
prior to emission (Jung et al., 2005). While it is possible for the neutral form to convert to the 
anionic form following excitation, this is not the most favorable reaction. The majority of 
excited, neutral fluorophores will convert briefly to the intermediate state, where 
fluorescence will occur followed by reversion back to the neutral state (Chattoraj et al., 
1996).  Interconversion between the neutral and anionic states is possible, but requires both 
proton transfer and conformational change to occur (Zimmer, 2002).  Similarly, the majority 
of anionic fluorophores will revert to the ground state following fluorescent emission, but 
could instead undergo a conformational change to the intermediate state and then continue 
on to adopt a neutral charge state (Chattoraj et al., 1996). 
In a wild type population, GFP contains a 6:1 ratio of neutral to anionic fluorophores (Tsien, 
1998), explaining why the major absorption peak is found at 397 nm. However, upon 
extended UV illumination this peak will begin to decrease and the minor peak will increase 
(Cubitt et al., 1995). This behavior corresponds to the photoisomerization of the neutral 
fluorophore form responsible for the major absorption peak being converted into the anionic 
form as discussed above. While the photoisomerization characteristics of GFP can prove 
problematic for quantification, they do allow for the study of protein movement by 
excitation with intense UV light at 397 nm followed by excitation at 475 nm in order to track 
the movement of the photoisomerized fluorophores (Yokoe & Meyer, 1996). 
3.4 Color shifted GFP variants 
Following the discovery of GFP it was quickly proven that amino acid substitutions were 
capable of altering its fluorescent characteristics.  Since that time, versions of GFP have been 
developed that fold more efficiently at higher temperatures (Crameri et al., 1996), avoid 
dimerization at high concentration (Zacharias et al., 2002), or fluoresce in the blue (Heim et 
al., 1994), cyan (Hein & Tsien, 1996), or yellow (Ormo et al., 1996) wavelengths. The history 
and development of these variants has been reviewed extensively in the past (Tsien, 1998; 
Zimmer, 2002), and they can now all be classified by dividing the known variants into seven 
classes based on spectral characteristics.  When applied in concert, these variants of the GFP 
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protein have given researchers the ability to use multiple GFP-based reporters in the same 
environment at the same time, improving the usefulness and range of this already dynamic 
protein. 
3.5 Red-shifted fluorescent reporter proteins for the mammalian environment 
To further red-shift fluorescent emission wavelengths beyond that of the GFP variants, a 
fluorescent protein from an entirely new organism was used as the starting point. This 
protein was the red fluorescent protein (dsRed) from the Discosoma corals.  dsRed is a 26 
kDa protein that has an excitation wavelength of 558 nm and a resulting emission 
wavelength of 583 nm. It is capable of producing fluorescence with a quantum yield of 0.24 
(Matz et al., 1999) but acts as a tetramer under wild-type conditions, making it problematic 
for use as an efficient reporter in its native state. To overcome the problems associated with 
its tetrameric quaternary structure, dsRed was engineered to functionally express 
fluorescence as a monomer (Campbell, R. et al., 2002) and then further refined through a 
process of directed evolution to produce the popular mCherry protein.  While mCherry is 
only 27% as bright as the original dsRed protein, it has improved photostability and red-
shifted excitation and emission wavelengths at 587 nm and 610 nm respectively, which 
allow it to function more efficiently in the mammalian cellular background (Shaner et al., 
2004). These red-shifted fluorescent reporter proteins are only a few examples of the type of 
improved fluorescent reporter proteins that have been developed for use in mammalian 
imaging, but are representative of the type of mutations that must be engineered to develop 
additional fluorescent reporters for this unique type of imaging. 
3.6 Examples of use as a mammalian biosensor 
3.6.1 Steady state imaging 
Steady state imaging is the classical hallmark of mammalian visualization. This process 
begins with transfecting the gene encoding the fluorescent reporter into a cell line. If the 
researcher is primarily concerned with intracellular processes, this may be all that is 
required.  Once the reporter protein is being expressed within the host cell, its presence can 
be visualized using fluorescent microscopy following excitation at the appropriate 
wavelength. If the goal is to determine the location or population size of the cells within a 
small animal model, the transfected line must first be introduced and then allowed to 
propagate within the host until it reaches a level capable of being detected through the 
native host tissue. This growth period can take several days depending on the size of the 
initial cellular inoculum. When these types of experiments are performed, it is most 
important to take into consideration the wavelength and brightness of the reporter protein 
used to ensure efficient performance. For example, when attempting to localize a single 
protein within a cell, the GFP protein can be fused to the protein of interest, and then 
quickly and easily visualized under fluorescence microscopy.  This is the strategy that was 
taken by Barak et. al. when they developed β-Arrestin 2/GFP fusions that were used to 
significantly improve detection of G-protein coupled receptor activation.  Expression of the 
GFP-fused proteins allowed the investigators to visualize how the conjugate responded to 
ligand mediated receptor activation using confocal microscopy in real-time using living cells 
(Barak et al., 1997). This work has been instrumental in monitoring G-coupled protein 
receptor activation, which represents the single most important target to date for drug 
development and medical therapy. However, while GFP provided an excellent target for 
www.intechopen.com
  
Biosensors for Health, Environment and Biosecurity 
 
476 
detection in single cells, when the goal is localization of a tumor cell population within a 
mouse model, a reporter such as mCherry should be considered because it would allow for 
emission in a more red-shifted wavelength, thereby improving the signal penetration 
through the additional host tissue and allowing for easier detection than would be expected 
from GFP. 
3.6.2 Multi-reporter imaging 
In its most basic form, multi-reporter imaging is simply an extension of steady state imaging 
following introduction of two or more reporter proteins.  Under these conditions, the genes 
for the reporter proteins are introduced into the cell and, following expression, they are 
exposed to their respective excitation signals in a stepwise manner. The resulting emission 
signals can be differentiated either temporally from the staggered excitation signal 
applications or simultaneously based on their differential wavelength characteristics.  In this 
type of approach the most important consideration should be the overlap of the chosen 
reporter excitation and emission wavelengths. Care must be used to select groupings of 
reporters that do not have overlapping emission and excitation signals.  If multiple reporters 
have similar excitation wavelengths, there will be no way to separate their expression times 
since they will be triggered simultaneously. Likewise, if multiple reporters share 
overlapping emission wavelengths, it may not be possible to differentiate their locations 
unless they have disparate excitation wavelengths and their expression is controlled 
temporally.  Finally, caution must be used to ensure the emission wavelength of one of the 
reporters is not within the excitation range of a simultaneously expressed reporter. Under 
these conditions the two signals cannot be differentiated and the initial signal can be 
partially or completely consumed during energy transfer to the second reporter in a process 
referred to as fluorescence resonance energy transfer (FRET). 
In some cases, this type of FRET is the desired outcome. FRET is often used to boost the 
overall fluorescent output of the reporter system by taking advantage of a high penetration 
excitation wavelength of one reporter, and the resulting increased emission properties of a 
second. Alternatively, FRET systems can be used to visualize the interaction of proteins 
within a cell. By creating fusions between two proteins of interest and fluorescent proteins 
such as GFP and its blue-shifted variant, it is possible to visualize when the two proteins of 
interest are interacting at a resolution greater than that achievable using traditional optical 
microscopy. This is possible because these reporters display overlapping emission and 
excitation wavelengths, thereby allowing investigators to determine where the fused 
proteins are interacting by using only a single excitation wavelength and reading the 
opposite partner’s excitation wavelength (Day, 1998).  
3.6.3 Measuring changes in cellular health 
There have been many examples of how fluorescent proteins can be used to monitor 
changes in cellular health, with an extensive review of these studies having been presented 
previously (Aguilera et al., 2006). In general, the methodology behind these types of 
experiments is fairly straightforward. The cell line of interest is first transfected with a 
fluorescent reporter protein, then, following determination of the baseline level of 
fluorescence, the cells are treated with a chemical or compound of interest and changes in 
fluorescent activity are monitored over time. Any resulting decrease in the fluorescent signal 
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relative to untreated control cells indicates a reduction in cellular health.  These types of 
experiments are beneficial because they can present a simple, high throughput method for 
screening large numbers of compounds prior to beginning more in depth analysis. 
3.7 Summary of advantages and disadvantages  
 
Advantages and Disadvantages of Fluorescent Reporters 
Advantages Disadvantages 
Diverse range of colors 
 
Quantitative correlation between signal 
strength and cell numbers 
 





Can be used in combination for multiple 
labeling 
Potentially high levels of background 
fluorescence upon excitation signal 
 
Can be subject to photobleaching, preventing 
repeated imaging 
 
Non-genetic system leads to diffusion during 
cellular division 
 
Photoexcitation can cause tissue damage at low 
wavelengths 
Table 1. Advantages and Disadvantages of Fluorescent Reporter Use in Mammalian 
Imaging 
4. Luciferase proteins that require exogenous substrate addition 
4.1 Introduction 
At the most basic level, a luciferase protein can be defined as any protein that, upon binding 
to its required substrate, produces a luminescent signal as a product of the ensuing 
enzymatic reaction. The discovery that this signal could be generated without the 
requirement for introduction of an excitatory light signal has been a mainstay of the 
biomedical imaging community because it allows for visualization without increased 
production of unwanted background fluorescence. However, unlike fluorescent reporter 
systems, the majority of luciferase systems require the addition of an exogenous chemical 
substrate to elicit their bioluminescent production.  While there are many different types of 
luciferase proteins that have been isolated to date, there are predominantly two main 
categories that are in common use today: luciferase proteins that utilize D-luciferin as a 
substrate and luciferase proteins that utilize coelenterazine as a substrate. While these two 
classes of luciferase proteins utilize different substrates and therefore different mechanisms 
of action, the end result of the reaction for each results in the production of a luminescent 
signal in the visible range that can often be detected at lower levels than their fluorescent 
counterparts due to the lack of endogenous bioluminescent production in mammalian tissue 
(Close, D., Xu et al., 2010). While this advantage is obvious, it is important to note that the 
injection of required substrate, be it either D-luciferin or coelenterazine, entails the 
introduction of additional concerns over the efficiency of substrate injection, the quality of 
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the substrate being used, the rate of substrate uptake and clearing in the subject tissue, and 
even the cost of the substrate itself. Although each of these factors could have deleterious 
effects on the outcome of a particular experiment, they have not prevented the luciferase 
requiring proteins from becoming the most popular method for visualization in mammalian 
tissues because of their ease of use and high signal quality. 
4.2 Luciferase proteins that utilize D-luciferin as an exogenous substrate 
The chemical 2-(4-hydroxybenzothiazol-2-yl)-2-thiazoline acid is more commonly referred 
to simply as D-luciferin (White, E.H. et al., 1961) and is the substrate utilized by the majority 
of terrestrial bioluminescent organisms. The majority of these organisms are from the order 
Coleoptera and are best represented by the common North American firefly Photinus pyralis 
and the click beetles (Fraga, 2008). Historically, research has focused on determining the 
structure and mechanism of action of the firefly luciferase protein (Luc) as a model for 
substrate-dependent luminescent production, and recent discoveries have indicated that this 
mechanism is similar among all luciferase proteins that use D-luciferin as a substrate (Wood, 
Lam, & McElroy, 1989).  Since its discovery, the Luc protein has grown into the most widely 
used of the bioluminescent reporter systems in mammalian imaging and therefore 
understanding its function is vital to interpreting the majority of published results on the 
subject. 
4.2.1 Firefly luciferase structure 
Luc is a monomeric protein composed of 550 amino acid residues with a molecular weight 
of 62 kDa (Conti et al., 1996). Originating from a eukaryotic organism, the genomic DNA 
encoding the Luc protein is comprised of seven exons and six introns that must be spliced 
out prior to translation in order to form the mature product (de Wet et al., 1986).  The 
primary sequence of Luc shares extensive sequence similarity with the acyl-CoA ligases and 
this homology has been exploited to determine the location of the active site as well as the 
binding sites for its required co-factors (Conti et al., 1996). One interesting feature of the 
protein sequence is a C-terminal tag that directs it to the peroxisome (Viviani, 2002), 
although it does have some functional features of a membrane protein such as a tendency to 
associate with phospholipids (Ugarova, 1989). 
The Luc protein can be divided into two major domains. The N-terminal domain is by far 
the larger of the two and comprises the first 436 residues.  The C-terminal domain is formed 
from residues 440 to 550, and is linked to the N-terminal domain by a 4 residue long flexible 
loop. The large N-terminal domain is rich in secondary structure and is home to an 
antiparallel -barrel and two -sheets that are flanked by -helices. While physically 
smaller, the C-terminal domain also contains a mix of secondary structures including two 
short antiparallel -strands and a three-stranded mixed -sheet associated with three -
helices arranged in an  +  structure. There are four short connecting regions in the crystal 
structure that are too disordered to interpret, however, these regions are all exposed to 
solvent and represent some of the most conserved residues in homologous proteins so their 
exact position is unlikely to effect structure-based predictions (Conti et al., 1996). 
The N-terminal -barrel is distorted into three distinct faces because of its interactions with 
the surrounding structures. Two of the three faces are formed by three-stranded antiparallel 
-sheets, while the third is comprised of two strands of the neighboring major -sheet and 
the disordered region connecting them. Because of this close interaction between the -
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barrel and the two major -sheets, concave depressions are formed on the surface of the 
protein in a “Y” shape. The two major -sheets in the N-terminal domain are each composed 
of eight strands with a core of parallel strands joined to -helices running antiparallel on 
either side of the sheet to form a five-layered ---- tertiary structure.  One sheet consists 
of five parallel and three antiparallel -strands with six associated helices with all but the 
last helix being formed from a continuous section of the polypeptide chain, while the other 
is split between six parallel and two antiparallel strands and six helices and is formed from 
two non-contiguous portions of the polypeptide (Conti et al., 1996). 
There is a wide cleft between the N and C-terminal domains that is bridged by residues 436 
to 440. Although the crystal structure does not include bound substrates, all of the invariant 
residues from the related adenylate-forming enzymes are located on the opposing faces of 
this cleft, sparking the hypothesis that the domains re-arranged following substrate binding 
(Conti et al., 1996).  This hypothesis has been bolstered by the recent crystallization and X-
ray analysis of the related luciferase protein from the Japanese firefly Luciola cruciata. This 
structure was obtained in the presence of bound substrates and shows a much closer 
association between the two domains (Nakatsu et al., 2006). It has even been proposed that 
the C-terminal domain changes orientation multiple times to carry out different steps in the 
luminescent reaction (Branchini, B.R. et al., 2005). 
In order to perform its luminescent reaction, Luc must bind with the luciferin, ATP-Mg2+, 
and oxygen (Hastings, J et al., 1953).  Despite the widespread use of Luc, the actual binding 
sites for these components have yet to be determined conclusively.  There are two current 
models put forth by Ugarova (Sandalova & Ugarova, 1999) and Branchini (Branchini, B. et 
al., 1998) that propose similar active site interactions.  Both models suggest that residues Arg 
218, His 245–Phe 247, Ala 313–Gly 320, and Lys 529 form the binding site for D-luciferin, 
with a hydrophobic surface being contributed directly by Ala 313, Ala 348, Ile 351, and Phe 
247.  The models differ in the importance of Arg 218, with Branchini suggesting that it 
interacts directly with luciferin phenolate (Branchini, B. et al., 1998) and Ugarova proposing 
that this interaction occurs with Arg 337.  These models were bolstered by the Luciola crystal 
structure which showed association at Phe 249, Thr 253, Leu 286, Glu 311–Ser 314, Arg 337–
Tyr 340, and Ala 348 (Nakatsu et al., 2006).  Unfortunately, confirmation of these active site 
models and the determination of the exact binding locations will have to wait until a crystal 
structure is published showing Luc bound to its substrates. 
4.2.2 Firefly luciferase mechanism of action 
The Luc protein catalyzes the oxidation of the reduced D-luciferin in the presence of ATP-
Mg2+ and oxygen to generate CO2, AMP, PPi, oxyluciferin, and yellow-green light at a 
wavelength of 562 nm. It is important to note that D-luciferin is a chiral molecule, and while 
both the D and L forms can bind to Luc and participate in adenylation reactions, only the D 
form is capable of continuing on in the reaction to generate light (Fraga, 2008). This reaction 
was originally reported to occur with a quantum yield of 0.88 (Seliger & McElroy, 1960), but 
has since been shown to actually achieve a quantum yield closer to only 0.41 (Ando et al., 
2007). Because of this high quantum yield, the reaction is well suited to use as a reporter 
with as few as 10-19 mol of luciferase (2.4 X 105 molecules) able to produce a light signal 
capable of being detected (Gould & Subramani, 1988). 
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It has been known since the early 1950’s that the chemical reaction underlying firefly 
luminescence is a two-step process that first requires adenylation of D-luciferin followed by 
oxidation and the production of light (Hastings, J et al., 1953).  Prior to the initiation of the 
reaction, the Luc protein must first bind to D-luciferin. However, at this time it is not yet 
capable of undergoing oxidation or producing light.  The first step in the generation of light 
is the adenylation of the bound D-luciferin with the release of pyrophosphate (Ugarova, 
1989).  The function of this adenylation is to increase the acidity of the C4 proton of the 
thiazoline ring on D-luciferin.  This allows for removal of a proton from C4 causing 
formation of a carbanion (McCapra, F. et al., 1968). This carbanion is then attacked by 
oxygen, displacing AMP and driving the formation of a cyclic peroxide with an associated 
carbonyl group (a dioxetanone ring).  As the bonds supporting this structure collapse, it 
becomes decarboxylated, releasing CO2 and forming an excited state of oxyluciferin in either 
the enol or keto form (Fig. 3) (Ugarova, 1989). 
 
 
Fig. 3. The firefly luciferase bioluminescent reaction. 
The luciferase protein holds the reduced luciferin to allow for adenylation (a).  This process 
is followed by a deprotonation reaction that leads to the formation of a carbanion (b) and 
attack by oxygen (c), driving the formation of a cyclic intermediate (d). As this intermediate 
decays, carbon dioxide is released, forming the excited state luciferin in either the keto (e) or 
enolate (f) form.  Used with permission from (Branchini, B. et al., 1998). 
The kinetics of this reaction can be altered by varying the concentration of the substrates, 
with low concentrations (in the nM range) showing steady light production and high 
concentrations (M range) producing a bright flash followed by decay to 5–10% of the 
maximum (DeLuca, Marlene et al., 1979). There are multiple possible inhibitory compounds 
that could be responsible for the kinetic profile generated under high substrate 
concentrations. It has previously been shown that even though oxyluciferin is a natural 
product of the luciferase reaction, it is capable of remaining bound as an inhibitor to 
enzymatic turnover (Denburg et al., 1969). The same was found to be true of another 
potential byproduct, L-AMP, which can account for up to 16% of the product formed during 
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the luminescent reaction (Fontes et al., 1998).  This may, in part, explain how the addition of 
CoA to the luminescent reaction can result in improved performance. When CoA is added 
during the initial steps of the reaction it prevents the fast signal decay normally observed, 
and when it is added following this decay it can promote re-initiation of the flash kinetics.  
This can be attributed to CoA’s interaction with L-AMP to form L-CoA, resulting in 
turnover of the Luc enzyme and reoccurrence of the luminescent reaction (Airth et al., 1958). 
4.2.3 Click beetle luciferase proteins 
While the Luc protein from Photinus pyralis is the most extensively studied of the D-
luciferin utilizing enzymes, it is certainly not the only example from within this order of 
organisms.  The insects represent a large related group of bioluminescent organisms, with 
over 2500 species reported to be capable of generating light (Viviani, 2002). While the vast 
majority of these luminescent reactions remain unstudied, the main exception is in the 
order Coleoptera (beetles) where systems have been characterized for the click beetles 
(Fraga, 2008). The main advantage of the click beetle luciferase proteins are that they are 
available in a wider array of colors than the firefly Luc protein. Despite these differences 
in emission wavelength, the substrates and mechanism of action are similar to that of the 
more well characterized Luc system, allowing for easy substitution with the Luc system if 
the need arises. Another advantage of the alternate color availability of the click beetle 
luciferases is that they can be used in conjunction with the Luc system and imaged 
simultaneously if a means of differentiating the individual emission wavelengths is 
available. 
While it was originally believed that the different colors of the click beetle luciferase proteins 
were the result of divergent luciferase structures, this was shown not to be the case when the 
sequences of four luciferase genes from Pyrophorus plagiophthalamus with four different 
emission spectra were sequenced and found that they shared up to 99% amino acid identity 
(Wood, Lam, Seliger et al., 1989). There are currently three mechanisms that have been 
proposed to explain the multiple bioluminescent colorations: the active site polarity hypothesis 
(DeLuca, M, 1969), the tautomerization hypothesis (White, E. & Branchini, 1975), and the 
geometry hypothesis (McCapra, F., Gilfoyle, DJ., Young, DW., Church, NJ., Spencer P., 1994). 
The active site polarity hypothesis is based on the idea that the wavelength of light 
produced is related to the microenvironment surrounding the luminescent protein during 
the reaction.  In non-polar solvents the spectrum is shifted towards blue and in polar 
solvents it is more red-shifted. It is questionable, however, if polarity fluctuations can 
account for large scale changes like those that have been observed in P. plagiophthalamus.  
The tautomerization hypothesis states that the wavelength of light produced is dependent 
on if either the enol or keto form of the luciferin is formed during the course of the reaction.  
A recent study has reported that by altering the substrate of the reaction, the keto form of 
the luciferin can produce either red or green light, making this hypothesis unlikely. Finally, 
the geometry hypothesis suggests that the geometry of the excited state oxyluciferin is 
responsible for determining the emission wavelength. In a 90 conformation it would 
achieve its lowest energy state and red light would be produced, whereas in the planar 
conformation it would be in its highest energy state and green light would be produced.  
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4.2.4 Summary of advantages and disadvantages 
 
Advantages and Disadvantages of the D-luciferin Utilizing Luciferase Proteins 
Advantages Disadvantages 
High sensitivity and low signal-to-noise ratio 
 
Quantitative correlation between signal strength and cell 
numbers 
 
Low background in animal tissues 
 
Variations of firefly luciferase (stabilized and red-shifted) 
and click beetle luciferases (red and green) are available 
 
Different colors allow multi-component monitoring 
Requires exogenous luciferin 
addition 
 
Fast consumption of luciferin can 
lead to unstable signal 
 
ATP and oxygen dependent 
 
Currently not practical for large 
animal models 
 
Table 2. Advantages and Disadvantages of Using D-luciferin Utilizing Luciferase Proteins in 
the Mammalian Cellular Environment 
4.3 Luciferase proteins that utilize coelenterazine as an exogenous substrate 
While the D-luciferin utilizing Luc system may be the most popular for mammalian imaging 
experiments, it is the coelenterazine utilizing luciferase proteins that are the most widely 
occurring. In nature there are examples of these types of luciferase proteins in cnidarians, 
copepods, chaetognaths, ctenophores, decapod shrimps, mysid shrimps, radiolarians, and 
some fish taxa as well (Greer & Szalay, 2002). The coelenterazine substrate has the chemical 
structure of 2-(p-hydroxybenzyl)-6-(p-hydroxyphenyl)-8-benzylimidazo-[1,2-a]pyrazin-3-
(7H)-one (Bhaumik & Gambhir, 2002), and under its native function is bound to an 
associated protein to prevent availability to the luciferase. The strength of this bond is 
dependent on changes in calcium dynamics within the host cell, with increases leading to 
the detachment and subsequent availability of the substrate to participate in the 
bioluminescent reaction (Anderson et al., 1974). This system has been adapted, however, so 
that when the luciferase protein is expressed in a host cell, the coelenterazine substrate can 
be supplied exogenously, triggering the production of light without the need for changes in 
intracellular calcium levels. The primary example of a coelenterazine utilizing reporter is the 
luciferase from the sea pansy Renilla reniformis (RLuc). This protein interacts with its 
coelenterazine substrate to produce bioluminescence at 480 nm (Bhaumik & Gambhir, 2002).  
Because this wavelength is relatively blue-shifted compared to the D-luciferin luciferase 
utilizing proteins and because the two reporters require dissimilar substrates for activation, 
RLuc can be used either as a stand-alone reporter system or in conjunction with the Luc 
variants to simultaneously image multiple locations within the host. This multi-functionality 
has lead to an increase in the popularity of RLuc for mammalian imaging in recent years. 
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4.3.1 Renilla luciferase structure 
Unlike the previously discussed luciferin proteins, those that utilize coelenterazine as a 
substrate have not been found to display high levels of structural similarity, even when 
originating from within the same family. This most likely indicates that they are 
predominantly the result of individual evolutionary events (Loening et al., 2007).  The 
structure of the RLuc gene from Renilla reniformis will be given as an example because it is 
the most laboratory relevant of the coelenterazine utilizing luciferase proteins, but caution 
should be used when attempting to interpret the associated mechanism of action with 
alternate luciferase proteins without first determining their structural discrepancies. 
The RLuc protein is a 37 kDa enzyme comprised of 311 amino acids that exists as a 
monomer in solution.  Crystal structures of the RLuc protein exist (both with and without 
bound substrate) at a resolution of 1.4 Å, however, these were constructed using a modified 
version of the protein that included 8 amino acid mutations (Loening et al., 2007).  These 
mutations were included because they allow for more efficient expression as compared to 
the native enzyme and have not been shown to have a deleterious effect on bioluminescent 
production (Loening et al., 2006). The overall structure of the RLuc enzyme can be broken 
down into two domains.  The core domain takes the form of an /-hydrolase fold (Loening 
et al., 2007), a structure composed of 8 -sheets connected by -helixes. This structure is 
common to hydrolytic enzymes and is known to contain a catalytic triad that is responsible 
for carrying out their associated enzymatic reaction (Ollis et al., 1992). The cap domain is 
located above the core domain and consists of the residues from 146 to 330, which make up 
the region between -helix “D” and -sheet “6” (Loening et al., 2007). 
The N terminal region of the protein is believed to exhibit a flexible conformation in 
solution, with the initial 10–15 residues capable of wrapping around the remainder of the 
protein towards the presumptive enzymatic pocket.  However, it is not believed that these 
residues are absolutely required for securing the bound substrate or for proper steric 
positioning. To illustrate this point, RLuc proteins that have had the first 14 residues 
removed are still capable of producing more than 25% of their original activity. It is believed 
instead that a 10 amino acid flexible region corresponding to residues 153–163 within the 
cap domain is responsible for these actions (Loening et al., 2007).  This is consistent with 
previously characterized, structurally similar enzymes and therefore more likely to be the 
case (Schanstra & Janssen, 1996). 
The active site is believed to center around the catalytic triad, which is composed of the 
amino acids Asp 120, Glu 144, and His 285.  This placement is consistent with that of other 
known /-hydrolase proteins, with the nucleophile (Asp 120) located immediately after 
the fifth -sheet (Loening et al., 2006).  This area is known as the “nucleophile elbow” and 
follows the general sequence pattern of Gly-X-(nucleophile)-X-Gly (Heikinheimo et al., 
1999). In RLuc these residues are Gly 118-His 119-Asp 120-Trp 121-Gly 122. Further 
evidence that this is indeed the location of the active site was gathered by mutational 
analysis which showed that the mutations most detrimental to enzyme function occurred 
either in one of the three proposed catalytic triad residues or in Asn 53, Trp 121, or Pro 220, 
three residues that reside in the rear of the proposed active site pocket. This pocket is 
surrounded by a ring of hydrophobic and aromatic residues such as isoleucine, valine, 
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4.3.2 Renilla luciferase mechanism of action  
In the Renilla luciferase bioluminescent reaction the luciferin (coelenterazine) undergoes 
oxidative decarboxylation in the presence of oxygen to produce CO2, the oxidized 
oxyluciferin, and light at a wavelength of 480 nm (Hart et al., 1978).  Under native 
conditions this reaction takes place within specialized subcelluar compartments called 
lumisomes, however, during the course of mammalian expression the protein will be 
located wherever the gene is targeted using common sequence tags.  Activation is also 
simplified during mammalian expression. Unlike under native conditions when the 
coelenterazine substrate would be trapped by an associated binding protein until changes in 
local calcium concentration gradients triggered its release, making it available for binding 
by the RLuc protein (Anderson et al., 1974), during exogenous expression these associated 
binding proteins are not natively present, and therefore the injection of coelenterazine is all 
that is required to elicit a bioluminescent response. 
The coelenterazine substrate can be thought of as containing three complex reaction sites 
that each serve a purpose during binding and subsequent oxidation following interaction 
with the RLuc protein.  The first domain (R1) is a p-hydroxy-phenyl group, the second (R2) 
is a benzyl ring, and the third (R3) is a p-hydroxy-benzyl ring.  While the exact binding 
locations of each region of the substrate has not been confirmed, docking simulations have 
suggested potential locations that can be used to support the current hypothesis for the 
RLuc mechanism of action.  These simulations suggest that the R1 group binds in a position 
where it is accessible to the catalytic triad of Asp 120, Glu 144 and His 285, possibly by 
stabilization due to interaction between the hydroxyl of the R1 group and Asn 53 of the 
RLuc protein.  Further stabilization would be provided by interaction of the R3 domain with 
the Thr 184 residue (Woo et al., 2008). 
Once the substrate has been bound and localized to the active site of RLuc, the chemical 
reaction occurs that produces the telltale bioluminescent signal.  This reaction appears to be 
similar to the chemical reaction that occurs in other coelenterazine utilizing luciferase 
proteins such as aequorin despite their structural differences (Anderson et al., 1974).  Once 
bound to RLuc, oxygen attaches at C2 resulting in the formation of a hydroperoxide.  This 
hydroperoxide then becomes deprotonated (presumably through interaction with the 
catalytic triad) and the resulting negative charge on the hydroperoxide then undergoes a 
nucleophilic attack on C3 of coelenterazine to irreversibly form a dioxetanone intermediate.  
It is this cyclization that then provides the energy required to drive the production of light 
from the overall reaction (Vysotski & Lee, 2004). As the bonds between newly cyclized 
oxygens collapse the peroxide is released as CO2 and the excited, anionic state of 
coelenterazine is formed.  As this form decays a photon is released, and finally the fully 
oxidized luciferin is formed and released (Hart et al., 1978). 
4.3.3 Gaussia luciferase 
Gaussia luciferase (GLuc) represents an interesting example of a coelenterazine utilizing 
luciferase protein that is naturally secreted from the cell.  GLuc is a small 19.9 kDa protein 
consisting of only 185 amino acids that, in the presence of its substrate coelenterazine, will 
produce a bioluminescent signal with a peak at 480 nm similar to RLuc.  However, GLuc has 
some interesting properties that set it apart from RLuc as an imaging target in the 
mammalian environment.  The most unique difference is that the GLuc protein can be 
encoded to either remain in the cell or be naturally excreted depending on the presence or 
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absence of an included signal peptide.  This property allows the resulting luminescent signal 
to be used either for localization within a cell or for facile high throughput screening using 
spent cell culture media without the need to disturb the cells via exposure to coelenterazine.  
In addition to the excretable nature of the GLuc protein, it has also been shown to produce a 
brighter bioluminescent signal than its RLuc counterpart following substrate exposure 
(Tannous et al., 2005).  This means that the same 480 nm bioluminescent signal can be 
achieved as during use with RLuc, but less of the luciferase protein is required to generate 
the same level of signal.  Therefore GLuc, without its associated excretory signal peptide, 
may be a suitable alternative to RLuc if imaging is required at extremely low cell population 
sizes.  While there are other coelenterazine utilizing luciferase proteins available, the 
advantages and utility of GLuc make it the main counterpart to RLuc for laboratory use 
today. 
4.3.4 Summary of advantages and disadvantages 
 




Quantitative correlation between signal strength 
and cell numbers 
 
Stabilized and red-shifted Renilla luciferase are 
available 
 
Secretion of Gaussia luciferase allows for subject-
independent bioluminescence measurement 
 
Requires exogenous coelenterazine 
addition 
 
Low anatomic resolution 
 
Increased background due to oxidation 




Fast consumption of coelenterazine can 
lead to unstable signal 
 
Currently not practical for large animal 
models 
Table 3. Advantages and Disadvantages of Using Coelenterazine Utilizing Luciferase 
Proteins in the Mammalian Cellular Environment 
4.4 Examples of use as a mammalian biosensor 
4.4.1 Steady state imaging 
Steady state imaging using substrate requiring bioluminescent protein reporters is 
performed in a similar fashion to imaging using fluorescent reporter proteins, only with the 
injection of the substrate chemical performed in place of stimulation with an excitation 
wavelength. The main advantage offered by the use of the bioluminescent systems is that the 
injection of substrate does not create background luminescence because there are no native 
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bioluminescent proteins in the mammalian tissue.  This allows researchers to achieve detection 
with much smaller cell population sizes when using bioluminescent reporter systems.  The 
most common use of steady state imaging using these types of reporter systems has been for 
the study of tumorigenesis and evaluation of tumor treatment.  For example, Kim and 
colleagues have demonstrated this advantage with the newest generation of these reporters 
designed for tumor detection.  These investigators were able to inject codon-optimized FLuc 
containing 4T1 mouse mammary tumor cells subcutaneously and then image single 
bioluminescent cells at a background ratio of 6:1 (Kim et al., 2010).  This experiment effectively 
demonstrates how substrate utilizing reporters can be used to continuously monitor cancer 
development from a single cell all the way to complete tumor formation. 
4.4.2 Multi-component bioluminescent imaging 
Because the substrate requiring bioluminescent reporter systems are dependent on 
activation by a specific substrate, commonly either D-luciferin or coelenterazine, it is 
possible to use one luciferase of each type simultaneously in the same host.  To trigger 
bioluminescent production from an individual reporter protein, its specific substrate is 
added. This design elicits luminescent production from the target while not activating the 
alternate bioluminescent reporter.  This type of experimental design allows for localization 
of multiple cellular groups from within a single cell or host animal.  It is also possible to use 
a bioluminescent reporter in conjunction with an associated fluorescent reporter in a manner 
similar to FRET, only in this case the original luminescent signal is bioluminescent in nature 
and not fluorescent.  This type of experiment is referred to as bioluminescence resonance 
energy transfer (BRET) and has been used by Angers et. al. to demonstrate the presence of 
G-protein coupled receptor dimers on the surface of living cells.  By tagging a subset of β2-
adrenergic receptor proteins with RLuc and a subset with the red-shifted variant of green 
fluorescent protein, YFP, it was possible to detect both a luminescent and fluorescent signal 
in cells expressing both variants, but no fluorescent signal in cells expressing only YFP since 
no fluorescent excitation signal was used (Angers et al., 2000). 
4.4.3 Overall tumor load imaging 
The naturally secreted nature of the GLuc protein has lead to interesting advances whereby 
it can be used to monitor overall tumor burden in small animal models without the 
requirement of directly imaging the host animal.  This has been demonstrated by Chung 
and colleagues who induced bioluminescence from blood samples of host animals suffering 
from tumors that had been tagged with the gene for expression of GLuc.  Since the GLuc 
protein was secreted into the blood it was possible to correlate bioluminescence of the blood 
sample with overall tumor load without ever having to introduce the coelenterazine 
substrate to the animal.  This process was capable of reporting on tumors at lower levels 
than would have been possible using traditional steady state tumor imaging, and was 
capable of reporting on the dynamics of tumor growth in response to treatment (Chung et 
al., 2009). 
4.5 Concerns related to substrate injection route 
When working with luciferase proteins that utilize an exogenous substrate in small animal 
models, it will be necessary to introduce the requisite substrate through injection.  However, 
the chosen route of substrate injection can have influential effects on the emission of a 
www.intechopen.com
Mammalian-Based Bioreporter Targets: Protein Expression  
for Bioluminescent and Fluorescent Detection in the Mammalian Cellular Background 
 
487 
luminescent signal.  As a result, although logistical concerns may be most pertinent to 
consideration for investigators, the method of injection should be considered in light of the 
proposed objectives of any study (Inoue et al., 2009).  The three most common substrate 
injection routes are intraperitoneal, intravenous, and subcutaneous.  Each results in the 
introduction of the substrate in a unique manner and, although each should elicit 
bioluminescent production of an expressed reporter protein, they will all do so on different 
time scales and with different expression kinetics.  It is therefore important to have a basic 
understanding of the resulting luminescent profiles of each type of injection prior to 
determining which is best suited to an individual experimental design. 
4.5.1 Intraperitoneal injection of substrate 
The appeal of intraperitoneal injection for the majority of researchers  is its convenience, 
however, following this route of injection the substrate must absorb across the peritoneum 
before reaching the luciferase expressing cell populations. Any variations in the rate of 
absorption can lead to variations in the resulting luminescent signal. These variations, even 
when subtle, can increase the difficulty of reproducing the luminescent results (Keyaerts et 
al., 2008).  In addition, investigator error can lead to injection into the bowel, causing a weak 
or non-existent luminescent signal that can be confused with a negative result (Baba et al., 
2007).  Because of the associated diffusion, intraperitoneal injection produces lower peak 
luminescence levels than alternate injection techniques when inducing light production in 
subcutaneous tumor models, however, it has been found that it can also overestimate tumor 
size when used to induce luminescence from intraperitoneal or spleen-localized tumors, due 
to direct contact between the luciferin and the luciferase expressing cells (Inoue et al., 2009).  
The greater availability of the luciferin to the luciferase containing cells increases the 
amount of bioluminescent output by allowing them greater access to their luciferin without 
being limited by diffusion through non-luciferase containing tissue.  This increases the 
influx of the luciferin compound into the cell due to the resulting increased concentration 
gradient. 
4.5.2 Intravenous injection of substrate 
Intravenous injection can be used to systematically profuse a test subject with D-luciferin or 
coelenterazine. It is also a facile method for exposing multiple tissue locations to the 
substrate on relatively similar timescales. Because the administration of the luciferin is 
systemic, it allows for lower doses to be administered to achieve similar luminescence 
intensities as would be seen using alternate injection routes (Keyaerts et al., 2008), however, 
studies using radio-labeled D-luciferin have indicated that the uptake rate of intravenously 
injected substrate is slower in the gastrointestinal organs, pancreas, and spleen than would 
be achieved using intraperitoneal injection (Lee et al., 2003).  It is also important to note that 
when intravenous injection is used, the resulting luminescent signal is often of a much 
shorter duration than would be observed using alternate injection routes (Inoue et al., 2009). 
4.5.3 Subcutaneous injection of substrate 
Subcutaneous injection is often used as an alternative to intraperitoneal injection in order to 
avoid the signal attenuation shortcomings of the intravenous injection route. Bryant et al. 
(Bryant et al., 2008) have demonstrated that repeated subcutaneous injection of luciferin can 
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provide a simple and accurate model for monitoring brain tumor growth in rats, and though 
there is concern that repeated injection could cause excessive tissue damage, it has been 
demonstrated that the repeated subcutaneous injection of D-luciferin or coelenterazine into 
an animal model results in minimal injection site damage while providing researchers with 
bioluminescent signals that correlate well with intraperitoneal substrate injection 
luminescent profiles, albeit with a longer lag time prior to reaching tumor models in the 
intraperitoneal space (Inoue et al., 2009). 
5. The bacterial luciferase proteins 
5.1 Introduction 
Luminescent bacteria are the most abundant and widely distributed of the light emitting 
organisms on earth and can be found in both aquatic (freshwater and marine) and terrestrial 
environments. Despite the diverse nature of bacterial bioluminescence, the majority of these 
organisms are classified into three genera: Vibrio, Photobacterium, and Photorhabdus.  Of these, 
only those from Photorhabdus have been discovered in terrestrial habitats (Meighen, 1991) 
and developed into reporters capable of functioning within the mammalian cellular 
environment (Close, D, Patterson et al., 2010).  It is the terrestrial nature of the bacterial 
luciferase (lux) genes from Photorhabdus that made them suitable for adoption and use in 
mammalian tissues.  The lux genes from the Vibrio and Photobacterium genera are marine in 
nature, and as such their protein products have been naturally adapted to function at lower 
ambient temperatures than those required for mammalian expression.  However, even with 
their propensity to function efficiently at 37°C, the Photorhabdus lux genes required extensive 
modification to carry out the bioluminescent reaction in a non-bacterial host cell.  Natively, 
the lux gene cassette consists of 5 genes organized sequentially in a single operon in the 
form luxCDABE.  The luxA and luxB gene products form the heterodimeric luciferase 
enzyme, and the luxD, luxC and luxE gene products form a transferase, a synthase, and a 
reductase respectfully, that work together to produce and regenerate the required myristyl 
aldehyde co-substrate from endogenous myristyl groups.  Because the substrates required 
by the luxAB heterodimer enzyme consist only of oxygen, FMNH2, and the aldehyde that is 
formed by the luxCDE genes, this system has the unique ability to produce bioluminescence 
without the addition of exogenous substrate addition (Meighen, 1991).  However, unlike the 
native, uncompartmentalized bacterial cellular environment, the mammalian intracellular 
environment does not contain high enough levels of reduced FMNH2 to support efficient 
bioluminescent production.  To alleviate this problem, a sixth lux gene must be co-expressed 
that is not present in all bacterial species.  This sixth gene, frp, encodes an NAD(P)H:flavin 
reductase that helps to cycle endogenous FMN into the required FMNH2 co-substrate 
(Close, D, Patterson et al., 2010). 
To function properly within a mammalian host cell, the 5 lux genes, as well as an additional 
flavin reductase gene (frp), must be expressed simultaneously and at high levels.  To 
accommodate these requirements the genes must be codon-optimized to the human codon 
preference and their expression linked via internal ribosomal entry elements or similar 
promoter independent intervening sequences.  This allows for the relatively normalized 
levels of expression while reducing the overall amount of foreign DNA that must be 
introduced and maintained in the host genome.  When expressed under these conditions, 
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the lux genes are capable of producing a luminescent signal in the mammalian host cell at 
490 nm without the need for any external stimulus (Close, D, Patterson et al., 2010).  
Although limited due to their relatively low luminescent yield compared to the luciferase-
dependent reporter systems and blue-shifted luminescent signal, the unique ability of 
substrate-free luminescent production makes the Lux system a user friendly and attractive 
alternative to the D-luciferin or coelenterazine utilizing systems. 
5.2 Bacterial luciferase structure 
The functional bacterial luciferase enzyme is a heterodimer with a molecular weight of 77 
kDa. The individual  and  subunits are the products of the luxA and luxB genes 
respectfully, and have molecular weights of 40 and 37 kDa.  The two subunits appear to be 
the result of a gene duplication event owing to an approximately 30% amino acid sequence 
identity (Meighen, 1991).  All previously characterized bacterial luciferases appear to be 
homologous and catalyze the same reaction, however, the majority of research has centered 
on the luciferase from the marine bacterium Vibrio harveyi, so the structure described in this 
review will be based on the protein from that organism along with its conventional 
numbering system. 
Individually the  and  subunits of the luciferase heterodimer formed by the luxA and luxB 
genes are capable of producing a very weak bioluminescent signal, but dimerization is 
required for the reaction to proceed at biologically relevant levels (Choi et al., 1995).  This 
finding, along with the similarities in structure between the two subunits would tend to 
implicate the dimer interface as the active site, however, the single active site has been 
proposed to exist only within the  subunit (Baldwin et al., 1995). Indeed, a recent crystal 
structure shows the oxidized FMN substrate bound to the  subunit only (Campbell, Z.T. et 
al., 2009). 
Both of the  and  subunits have similar overall conformations, and assemble into a single-
domain eight-stranded / barrel motif (also known as a TIM barrel after the first identified 
protein with that structure, triose-phosphate isomerase).  The interiors of these barrels are 
packed with hydrophobic residues, as would be expected to aid in folding, while the N-
terminal residues, which are exposed to solvent, contain hydrophilic residues.  The C-
terminal ends are hydrophobic, but are protected from solvent access by the presence of two 
antiparallel -helices.  The dimerization of the two subunits is mediated by a parallel four 
helix bundle centered on a pseudo two-fold axis of symmetry as it relates to the  and  
subunit orientation.  This region is highly populated with glycines and alanines, which 
allows for close contact between the two helical bundles.  The majority of binding force is 
provided by van der Waals interactions across the 2150 Å2 surface area, but twenty-two 
proposed hydrogen bonds, as well as forty-five water-mediated intersubunit hydrogen 
bonds and a series of hydrophobic interactions also aid in attachment (Fisher et al., 1996). 
The active site is most probably a large, open cavity on the  subunit that is open to solvent 
at the C-terminal end of the barrel structure proximal to the  subunit.  Crystal structures of 
the enzyme with an associated flavin show that it is bound here with the isoalloxazine ring 
in a planar conformation.  The ribitol portion of the flavin extends away at an ~45 angle 
while the phosphate is stabilized by the side chains of Arg 107, Arg 125, Glu 175, Ser 176, 
Thr 179, and the backbone amide of Glu 175.  The isoalloxanine ring is held in place through 
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backbone contacts with Glu 175 and Phe 6 and the ribitol interactions cannot be clearly 
defined as occurring directly with the protein or being mediated by co-bound water 
molecules, but they can be localized to individual residues.  The carbonyl oxygen at C2 of 
the ribitol hydrogen bonds with backbone amide hydrogen of Tyr 110, the nitrogen at 
position three forms a hydrogen bond with the backbone carbonyl oxygen of Glu 43, while 
the carbonyl oxygen at C4 hydrogen bonds to either the backbone amide proton or the enol 
form of the backbone carbonyl oxygen of Ala 75.  It is likely, but as of yet unproven, that the 
aldehyde binding location is adjacent to the benzenoid portion of the isoalloxane ring 
because of its proximity to the FMN binding site, size, and abundance of tryptophan and 
phenylalanine residues (Campbell, Z.T. et al., 2009). 
5.3 Bacterial luciferase mechanism of action 
When the bacterial luciferase enzyme is supplied with oxygen, FMNH2, and a long chain 
aliphatic aldehyde it is able to produce light at a wavelength of 490 nm. The natural 
aldehyde for this reaction is believed to be tetradecanal, however, the enzyme is capable of 
functioning with alternative aldehydes as substrates (Meighen, 1991).  The first step in the 
generation of light from these substrates is the binding of FMNH2 by the luciferase enzyme 
and until recently its active site on the enzyme was not known.  It has recently been 
confirmed that FMNH2 binds on the  subunit in a large valley on the C-terminal end of the 
-barrel structure (Campbell, Z.T. et al., 2009).  The nature of the interactions between 
FMNH2 and the amino acid residues in this area is discussed in the structure section above.   
In order for the reaction to proceed the luciferase must undergo a conformational change 
following FMNH2 attachment.  This movement is primarily expressed in a short section of 
residues known as the protease liable region: a section of 29 amino acids residing on a 
disordered region of the  subunit joining -helix 7a to -strand 7a.  The majority of 
residues in this sequence are unique to the  subunit and have long been implicated in the 
luminescent mechanism (Baldwin et al., 1995).  Following attachment of FMNH2 this region 
becomes more ordered and is stabilized by an intersubunit interaction between Phe 272 of 
the  subunit and Tyr 115 of the  subunit. This conformational change has been theorized 
to stabilize the  subunit in a conformation favorable for the luciferase reaction to occur 
(Campbell, Z.T. et al., 2009). 
NMR studies have suggested that FMNH2 binds to the enzyme in its anionic state (FMNH-) 
(Vervoort et al., 1986).  With the flavin bound to the enzyme, molecular oxygen then binds 
to the C4a atom to form an intermediate 4a-hydroperoxy-5-hydroflavin (Nemtseva & 
Kudryasheva, 2007).  It is important to note that this important C4a atom was determined to 
be in close proximity to a reactive thiol from the side chain of Cys 106 on the  subunit 
(Campbell, Z.T. et al., 2009), a residue that has long been hypothesized to play a role in the 
luminescent reaction, but since has been proven to be non-reactive through mutational 
analysis (Baldwin et al., 1987).    
It has been shown, however, that C4a is the central atom for the luciferase reaction and, 
following establishment of the hydroperoxide there, it is capable of interaction with the 
aldehyde substrate via its oxygen molecule to form a peroxyhemiacetal group. This complex 
then undergoes a transformation (through an unknown intermediate or series of 
intermediates) to an excited state generally accepted to be a luciferase-bound 4a-hydroxy-5-
hydroflavin mononucleotide, which then decays to give oxidized FMN, a corresponding 
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aliphatic acid, and light (Fig. 4) (Nemtseva & Kudryasheva, 2007). There have classically 
been many theories proposed to explain the exact process required for light emission that 
continue to expand today as technology for detecting the intermediate complexes has 
improved (Hastings, JW & Nealson, 1977; Nemtseva & Kudryasheva, 2007). 
 
 
Fig. 4. Bioluminescent reaction catalyzed by the bacterial luciferase genes. 
A) The luciferase is formed from a heterodimer of the luxA and luxB gene products.  The 
aliphatic aldehyde is supplied and regenerated by the products of the luxC, luxD, and luxE 
genes. The required oxygen and reduced riboflavin phosphate substrates are scavenged 
from endogenous metabolic processes, however, the flavin reducatse gene (frp) aids in 
reduced flavin turnover rates in some species. B) The production of light, catalyzed by the 
products of the luxAB genes, results from the decay of a high energy intermediate (R1 = 
C13H27).  
5.4 Use as a mammalian biosensor 
Bacterial luciferase is the newest of the bioluminescent reporter proteins to be demonstrated 
for use with mammalian tissues.  As a result, there have not been extensive publications on 
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its use under these conditions.  The initial reports, however, have been promising, with lux-
containing cells capable of being used for steady state imaging both in culture and in small 
animal models (Close, D, Patterson et al., 2010). If the lux cassette genes undergo widespread 
adoption there is no reason to believe they will not become capable of functioning in roles 
similar to the substrate requiring bioluminescent reporter proteins. The main drawback of the 
lux genes for function in the mammalian cellular background has been their low signal 
strength. As a result, they may not be as well suited for small population size cellular imaging 
or deep tissue imaging, where their weak signal may be attenuated prior to detection.  
However, it is important to keep in mind that as this reporter system becomes more common 
it will be subjected to optimization in a process similar to the other common reporter systems. 
If this is the case the utility of the lux reporter system should continue to increase with time. 
5.5 Summary of advantages and disadvantages 
 
Advantages and Disadvantages of the Bacterial Luciferase Gene Cassette 
Advantages Disadvantages 
High sensitivity and low signal-to-noise ratio 
 
Quantitative correlation between signal strength 
and cell numbers 
 
Fully autonomous system, no requirement for 






Rapid detection permitting real-time monitoring 
Bioluminescence at 490 nm prone to 
absorption in animal tissues 
 
Low anatomic resolution 
 
NADPH and oxygen dependent 
 
Not as bright as other luciferases 
 
Currently not practical for large animal 
models 
 
Short history of use 
Table 4. Advantages and Disadvantages of Using the Bacterial Luciferase Gene Cassette in 
the Mammalian Cellular Environment 
6. Conclusions 
This chapter has presented only the most basic and widely used of the mammalian reporter 
proteins and is by no means exhaustive. It is important to recognize that there is no 
universally recognized optimal reporter system and that the choice of a reporter target 
should be made in light of the specific demands of each experimental design.  Each reporter 
system has its own advantages and disadvantages, and each can be adapted to work under 
multiple imaging scenarios.  The constant introduction of improved reporter protein targets 
www.intechopen.com
Mammalian-Based Bioreporter Targets: Protein Expression  
for Bioluminescent and Fluorescent Detection in the Mammalian Cellular Background 
 
493 
and modifications to existing reporter proteins suggest that the future of imaging in 
mammalian tissues should be bright for years to come. 
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